Clinical Trial Update: A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating oral ZYGK1 in healthy volunteers for diabetes is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• ZYGK1 (ZYGK1)

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Diabetes | Phase 1 | Status: SUSPENDED